Carlumab (Anti-CCL2 / MCP1)

Synonyms: CNTO 888

Carlumab (Anti-CCL2 / MCP1) is a humanised monoclonal antibody targeting CCL2 with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer. MW:145.5 KD.

Carlumab (Anti-CCL2 / MCP1)

Click to purchase the isotype control of Carlumab (Anti-CCL2 / MCP1)

Purity & Quality Control

Batch: A257301 Purity: 99% Protein concentration: 3.8mg/ml Endotoxin Level: <1EU/mg
99

Choose Selective Immunology & Inflammation related Inhibitors

Biological Activity

Description Carlumab (Anti-CCL2 / MCP1) is a humanised monoclonal antibody targeting CCL2 with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer. MW:145.5 KD.

Product Details

CAS No. 915404-94-3
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Carlumab (Anti-CCL2 / MCP1) | Carlumab (Anti-CCL2 / MCP1) supplier | purchase Carlumab (Anti-CCL2 / MCP1) | Carlumab (Anti-CCL2 / MCP1) cost | Carlumab (Anti-CCL2 / MCP1) manufacturer | order Carlumab (Anti-CCL2 / MCP1) | Carlumab (Anti-CCL2 / MCP1) distributor